6533b835fe1ef96bd129ffa6
RESEARCH PRODUCT
Immune cell score, PD-L1 expression and prognosis in esophageal cancer.
Anna JunttilaJuha P. VäyrynenTeijo KuopioMaarit AhtiainenJohanna MrenaEero SihvoOlli Helminensubject
Oncologymedicine.medical_specialtyEsophageal NeoplasmsCellMEDLINEB7-H1 Antigen030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineImmune systemLymphocytes Tumor-InfiltratingInternal medicinemedicineBiomarkers TumorHumansRadiology Nuclear Medicine and imagingCancer deathbusiness.industryCancerHematologyGeneral MedicineEsophageal cancermedicine.diseasePrognosismedicine.anatomical_structureOncology030220 oncology & carcinogenesisPd l1 expressionbusinessdescription
Esophageal cancer (EC) is the ninth most common cancer worldwide and the sixth leading cause of cancer death [1]. Despite improvements in the treatment of EC, the general outcome remains poor [2–4]...
year | journal | country | edition | language |
---|---|---|---|---|
2021-01-13 | Acta oncologica (Stockholm, Sweden) |